ESC presentations from August now online

BearDownAZ

------------------------------------------------------------------------------------------

A novel approach for high CV risk patients with diabetes: The potential of epigenetics

August 28th 2016, ESC, Rome

Kausik Ray, MD - Imperial College London, United Kingdom:

"The high risk diabetes patient with cardiovascular disease: What else can we target to reduce cardiovascular risk?"

Jorge Plutzky, MD - Brigham and Women’s Hospital, Harvard Medical School, Boston, USA:

"Understanding BET inhibition as a novel pathway for cardiovascular risk modulation"

John Kastelein, MD - Academic Medical Centre, Amsterdam, The Netherlands:

"BET inhibition in cardiovascular disease: A new dawn?"